Published in PLoS One on December 15, 2011
Physiology and metabolism of tissue-engineered skeletal muscle. Exp Biol Med (Maywood) (2014) 0.93
Human muscle-derived stem/progenitor cells promote functional murine peripheral nerve regeneration. J Clin Invest (2014) 0.87
NF-κB inhibition reveals a novel role for HGF during skeletal muscle repair. Cell Death Dis (2015) 0.83
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population. Mol Cancer (2016) 0.82
Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice. Hum Mol Genet (2014) 0.81
HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regeneration. J Clin Invest (2012) 0.78
Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation. PLoS One (2015) 0.77
The Mutual Interactions between Mesenchymal Stem Cells and Myoblasts in an Autologous Co-Culture Model. PLoS One (2016) 0.76
Applications of skeletal muscle progenitor cells for neuromuscular diseases. Am J Stem Cells (2012) 0.75
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
"Stemness": transcriptional profiling of embryonic and adult stem cells. Science (2002) 15.55
A stem cell molecular signature. Science (2002) 14.47
Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature (2009) 10.31
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol (2009) 8.42
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature (2002) 7.88
Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol (1994) 7.36
The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science (1989) 6.80
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature (1992) 6.37
NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science (2000) 5.20
Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell (2008) 4.92
DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science (2002) 4.88
Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol (2002) 4.61
Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol (2005) 4.47
Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res (1999) 4.34
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol (2009) 4.27
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A (1999) 3.91
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther (2007) 3.69
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood (2004) 3.41
Molecular mechanisms of "detachment-induced apoptosis--Anoikis". Apoptosis (2002) 3.05
Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells (2005) 2.67
Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol (1998) 2.57
The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev (2011) 2.56
The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev Biol (1970) 2.52
Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol (2007) 2.41
Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc (2008) 2.26
Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J (1998) 2.25
The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med (1997) 2.24
Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol (2008) 2.16
ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev (2010) 2.07
Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science (1996) 2.03
Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood (2004) 1.96
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood (2005) 1.80
Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem (2004) 1.73
Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice. J Biol Chem (2007) 1.70
The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev Biol (1983) 1.64
Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther (2005) 1.59
Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol (2002) 1.58
Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle (2009) 1.56
Cytolytic pathways in haematopoietic stem-cell transplantation. Nat Rev Immunol (2002) 1.48
Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther (2001) 1.42
Concise review: aldehyde dehydrogenase bright stem and progenitor cell populations from normal tissues: characteristics, activities, and emerging uses in regenerative medicine. Stem Cells (2011) 1.41
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood (2009) 1.40
A mitochondria-targeted nitroxide/hemigramicidin S conjugate protects mouse embryonic cells against gamma irradiation. Int J Radiat Oncol Biol Phys (2008) 1.39
Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med (2000) 1.32
Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy (2007) 1.28
Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol (1997) 1.22
Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn (2003) 1.21
Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood (2007) 1.21
Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell (2008) 1.19
The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci (2002) 1.19
Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther (1994) 1.19
Redox regulation and its emerging roles in stem cells and stem-like cancer cells. Antioxid Redox Signal (2009) 1.18
Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes (2002) 1.17
Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One (2010) 1.17
Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: a modulator of chondrogenesis. J Cell Biol (1997) 1.13
Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol (2003) 1.13
Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. BMC Biol (2009) 1.13
Mechanisms of muscle stem cell expansion with cytokines. Stem Cells (2002) 1.10
Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol (1993) 1.10
Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Ann Surg (2007) 1.06
Age-dependent imbalance of the antioxidative system in human satellite cells. Exp Gerontol (2004) 1.05
Automated measurement of cell motility and proliferation. BMC Cell Biol (2005) 1.02
Melanoma cell adhesion molecule is a novel marker for human fetal myogenic cells and affects myoblast fusion. J Cell Sci (2006) 1.01
Retinoic acid enhances skeletal myogenesis in human embryonic stem cells by expanding the premyogenic progenitor population. Stem Cell Rev (2012) 1.00
Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells. J Cell Mol Med (2011) 0.99
Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther (2000) 0.99
Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther (2010) 0.98
Retinoic acid induces adult muscle cell differentiation mediated by the retinoic acid receptor-alpha. J Cell Physiol (1993) 0.97
Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies. Transplantation (2007) 0.95
Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants. Crit Care Med (2007) 0.95
Stem cells to treat muscular dystrophies - where are we? Neuromuscul Disord (2010) 0.92
Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol Ther (2009) 0.90
Intramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data. Expert Opin Biol Ther (2011) 0.90
Effect of glutathione redox state on Leydig cell susceptibility to acute oxidative stress. Mol Cell Endocrinol (2010) 0.86
Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio. Radiat Res (1983) 0.86
Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation. Chem Biol Interact (2011) 0.86
Retinoic acid receptors and muscle b-HLH proteins: partners in retinoid-induced myogenesis. Oncogene (1998) 0.83
MnSOD marks cord blood late outgrowth endothelial cells and accompanies robust resistance to oxidative stress. Biochem Biophys Res Commun (2006) 0.82
The effects of natural and synthetic retinoids on the differentiation of RCJ C5.18 chondrogenic cells. Teratology (1994) 0.77
[The sex of muscle stem cells: must it be taken into account?]. Med Sci (Paris) (2007) 0.76
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol (2002) 4.61
Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther (2007) 3.69
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol (2004) 2.78
Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest (2002) 2.59
Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol (2007) 2.41
Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc (2008) 2.26
A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol (2007) 2.26
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone (2005) 2.26
IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med (2010) 2.15
Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum (2006) 2.08
A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol (2007) 2.01
Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem (2007) 1.96
VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res (2005) 1.96
NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest (2012) 1.91
Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol (2008) 1.85
Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med (2008) 1.83
Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol (2002) 1.74
Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve (2003) 1.61
Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther (2005) 1.59
Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev (2009) 1.51
Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials (2007) 1.48
Purification and culture of human blood vessel-associated progenitor cells. Curr Protoc Stem Cell Biol (2008) 1.42
Human pericytes for ischemic heart repair. Stem Cells (2013) 1.39
Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol (2003) 1.38
Enhancement of tendon-bone integration of anterior cruciate ligament grafts with bone morphogenetic protein-2 gene transfer: a histological and biomechanical study. J Bone Joint Surg Am (2002) 1.38
Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat Commun (2012) 1.37
Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle- and bone-like subpopulations. Stem Cells (2007) 1.37
Tissue engineering and developmental biology: going biomimetic. Tissue Eng (2006) 1.34
The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med (2005) 1.33
Mouse adipose-derived stem cells undergo multilineage differentiation in vitro but primarily osteogenic and chondrogenic differentiation in vivo. Tissue Eng (2006) 1.32
Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum (2009) 1.31
Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol (2008) 1.28
Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol (1985) (2003) 1.28
Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther (2009) 1.25
Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J Bone Miner Res (2005) 1.25
Pericyte-based human tissue engineered vascular grafts. Biomaterials (2010) 1.25
Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology (2003) 1.21
The vascular wall as a source of stem cells. Ann N Y Acad Sci (2005) 1.20
Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell (2008) 1.19
BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther (2002) 1.19
The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci (2002) 1.19
Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials (2007) 1.18
Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J Bone Miner Res (2006) 1.18
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am (2004) 1.16
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am J Pathol (2005) 1.16
Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res (2003) 1.15
In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A (2010) 1.14
Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. J Cell Physiol (2008) 1.11
Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum Gene Ther (2002) 1.11
Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res Ther (2014) 1.10
Differential effect of BMP4 on NIH/3T3 and C2C12 cells: implications for endochondral bone formation. J Bone Miner Res (2005) 1.09
Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha. J Appl Physiol (1985) (2006) 1.09
Accelerated aging of intervertebral discs in a mouse model of progeria. J Orthop Res (2010) 1.08
The synergistic effect of treadmill running on stem-cell transplantation to heal injured skeletal muscle. Tissue Eng Part A (2010) 1.08
Placental perivascular cells for human muscle regeneration. Stem Cells Dev (2010) 1.08
Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol (2011) 1.07
The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A (2009) 1.07
Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomater (2008) 1.07
Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med (2008) 1.07
Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol (2002) 1.07
Testing the critical size in calvarial bone defects: revisiting the concept of a critical-size defect. Plast Reconstr Surg (2010) 1.06
Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction. Cardiovasc Res (2009) 1.05
Muscle-derived stem cells for musculoskeletal tissue regeneration and repair. Transpl Immunol (2004) 1.04
The influence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair. Arthritis Rheum (2008) 1.04
Human blood-vessel-derived stem cells for tissue repair and regeneration. J Biomed Biotechnol (2012) 1.04
Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Miner Res (2007) 1.04
Matrix metalloproteinase-1 therapy improves muscle healing. J Appl Physiol (1985) (2007) 1.04
Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. J Bone Joint Surg Am (2013) 1.03
Biologic approaches to enhance rotator cuff healing after injury. J Shoulder Elbow Surg (2012) 1.03
AAV-directed muscular dystrophy gene therapy. Expert Opin Biol Ther (2010) 1.03
Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity. Stem Cells (2015) 1.02
Isolation and characterization of human anterior cruciate ligament-derived vascular stem cells. Stem Cells Dev (2011) 1.02
Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. J Am Acad Orthop Surg (2008) 1.02
Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells. Sarcoma (2013) 1.02
Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad Sci U S A (2011) 1.02
Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther (2007) 1.02
Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum (2009) 0.99
Intramuscular transplantation of muscle-derived stem cells accelerates skeletal muscle healing after contusion injury via enhancement of angiogenesis. Am J Sports Med (2011) 0.99
Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology (2004) 0.99
Noninvasive monitoring and tracking of muscle stem cell transplants. Transplantation (2004) 0.99
Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells. Front Oncol (2013) 0.98
Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther (2010) 0.98
The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscular pathology. Am J Phys Med Rehabil (2009) 0.98
The effect of relaxin treatment on skeletal muscle injuries. Am J Sports Med (2005) 0.97
Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther (2011) 0.97
Engineering spatial control of multiple differentiation fates within a stem cell population. Biomaterials (2011) 0.97
Noninvasive monitoring of stem cell transfer for muscle disorders. Magn Reson Med (2004) 0.97
The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium. Biomaterials (2012) 0.96
Skeletal muscle-derived stem cells: implications for cell-mediated therapies. Medicina (Kaunas) (2011) 0.96
Gene therapy and tissue engineering based on muscle-derived stem cells. Curr Opin Mol Ther (2002) 0.95
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells. Mol Ther (2011) 0.95
Therapeutic advantage in selective ligament augmentation for partial tears of the anterior cruciate ligament: results in an animal model. Am J Sports Med (2013) 0.95
VEGF and BMP expression in mouse osteosarcoma cells. Clin Orthop Relat Res (2006) 0.95
Study of muscle cell dedifferentiation after skeletal muscle injury of mice with a Cre-Lox system. PLoS One (2011) 0.94
Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials (2010) 0.94
Stem cells for the treatment of skeletal muscle injury. Clin Sports Med (2009) 0.94